Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.
Ankyra has raised $45.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Ankyra's investors include Sands Capital Ventures, Polaris Partners, Fidelity, Mithril Capital Management, Spring Mountain Capital.
Ankyra is headquartered in Boston, United States.
Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.
Ankyra is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ankyra — Funding & Investors." VCBacked, November 12, 2021, https://www.vcbacked.co/company/ankyra. Accessed November 17, 2026.
VCBacked. (2021). Ankyra — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/ankyra
{{cite web |title=Ankyra — Funding & Investors |url=https://www.vcbacked.co/company/ankyra |website=VCBacked |access-date=November 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Ankyra? Request a listing update